Genertec Universal Medical Group Company Limited 2666.HK

Financial Services · Credit Services · valued as of 2026-11-02 · statements 2025-12-31

Average Intrinsic Value
$15.34B
Market Cap
$1.13B
Margin of Safety
92.6%
Intrinsic / Market Ratio
13.54

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

37.86B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

4.57B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

3.58B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

15.34B USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

15.34B USD

from the sum above

Market Cap

1.13B USD

today's price times the shares

Intrinsic Value ÷ Market Cap

13.54×

the ratio the screener ranks by; Margin of Safety +92.6% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 37.86B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)34.98B USD
−②Net Debt Today0 USD
+③Growth Value2.88B USD
=Value37.86B USD

EPV of the Operations (NOPAT over WACC)

34.98B USD

Net debt today

0 USD

Growth Value

+2.88B USD

Value

37.86B USD

①EPV (earnings power value)

34.98B USD

②Net Debt Today

0 USD

③Growth Value

2.88B USD

Market value

Market Cap1.13B USD

Today's price times the shares.

Value vs market

Margin of Safety+97.0%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 4.57B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE2.36B USD
+②Equity at Year 15, Today2.21B USD
=Value4.57B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

2.36B USD

②Equity at Year 15, Today

2.21B USD

Market value

Market Cap1.13B USD

Today's price times the shares.

Value vs market

Margin of Safety+75.2%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 3.58B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).

The projection was not made (a change in working capital above half the operating profit in the latest three years), so the value is the book value today, 3.58B USD, as the screener leaves it.

①Present Value of the 15 Years of FCFF

Not in the value

②Invested Capital at Year 15, Today

Not in the value

③Net Debt Today

Not in the value

Market value

Market Cap1.13B USD

Today's price times the shares.

Value vs market

Margin of Safety+68.4%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 1.13%
weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.58×Market Risk Premium 6.00%= 7.97%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 100.38M USDPretax Income 431.98M USD= 23.24%

The tax the interest saves.

Interest Expense =EBIT 441.90M USD−Pretax Income 431.98M USD= 9.92M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 9.92M USDTotal Debt 7.55B USD×(1 − Tax Rate for WACC 23.24%)= 0.10%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 7.55B USDMarket Cap + Total Debt 1.13B USD + 7.55B USD= 86.95%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 13.05%×Cost of Equity 7.97%+Debt Weight 86.95%×Cost of Debt 0.10%= 1.13%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2025-12-31.

Total Assets 12.06B USD − Total Liabilities 8.48B USD = Book Value Today 3.58B USD

Net debt today 0: a bank's debt is the money it lends on, not how the business is financed.

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 16.5%at most 5%does not pass2,014,204,924 / 1,891,539,661
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets4.2%at least -10.0%passes(826.48M USD − 316.06M USD) ÷ 12.06B USD
Price to bookMarket Cap ÷ Book Value Today0.32×at most 3×passes1.13B USD ÷ 3.58B USD
Operating marginOperating Income ÷ Revenue21.8%above 10.0%passes466.72M USD ÷ 2.14B USD
Revenue growthRevenue ÷ Revenue a Year Before − 114.1%above 10.0%passes2.14B USD / 1.87B USD
Net cash(Cash − Total Debt) ÷ Market Cap-639.6%above -30%does not pass(301.58M USD − 7.55B USD) ÷ 1.13B USD
Operating efficiencyOperating Income ÷ Gross Profit64.8%above 25.0%passes466.72M USD ÷ 719.70M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Market data
The data provider's own ratios and the analysts' consensus, read beside the valuation, never in it.

Share price

4 USD

Enterprise value

60.18B USD

market cap plus net debt

EV / EBITDA

—

Price / book

0.35×

the provider's book

Price / earnings

3.44×

Return on equity

9.6%

the provider's, not the engine's

Profit margin

15.9%

Revenue growth

-6.6%

Analyst target, mean

7 USD

Analysts

1

opinions in the consensus

Financial Statements

The income statement, the balance sheet and the cash flow the screener holds, year by year, in USD.

Financial statements, year by year
The annual lines the screener holds today, in USD at each period's rate; the figures this valuation read are in its calculation above.
USD2022202320242025
Income statement

Revenue

1.74B1.92B1.87B2.14B

Gross profit

646.09M643.93M629.81M719.70M

Operating income

481.21M455.19M423.38M466.72M

EBITDA

operating income before depreciation and amortisation

457.29M480.84M488.30M554.71M

Pretax income

388.62M403.70M398.74M431.98M

Net income

281.74M297.23M288.58M316.06M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

300.15M286.90M286.04M346.41M

R&D

————
Balance sheet, year end

Total assets

11.07B11.32B11.80B12.06B

Total liabilities

8.23B8.45B8.66B8.48B

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

2.25B2.44B2.59B3.00B

Total debt

7.29B7.35B7.75B7.55B

Cash and equivalents

388.91M401.27M326.34M301.58M

Net PP&E

fixed assets after depreciation

715.21M782.11M1.05B1.11B

Working capital

current assets less current liabilities

244.14M87.57M611.39M1.38B
Cash flow

Operating cash flow

292.13M703.39M156.13M826.48M

Capital expenditure

paid out, so below zero

-88.82M-126.32M-172.14M-141.49M

Depreciation and amortisation

63.55M71.64M82.60M112.81M

Free cash flow

operating cash flow plus capital expenditure

203.30M577.07M-16.01M684.98M